Christine Lange, in Ballston Lake, NE - Nurse Practitioner

Christine Lange, is a Nurse Practitioner - Pediatrics based in Ballston Lake, Nebraska. Christine Lange is licensed to practice in New York (license number F330876-1) and her current practice location is 318 Ruhle Rd S, Ballston Lake, Nebraska. She can be reached at her office (for appointments etc.) via phone at (518) 899-4133.

NPI number for Christine Lange is 1760697049 and her current mailing address is 318 Ruhle Rd S, Ballston Lake, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1760697049.

Contact Information

	Christine Lange,
	318 Ruhle Rd S, Ballston Lake, NE 12019
	(518) 899-4133
	(518) 899-5764

Provider's Profile

Full Name	Christine Lange
Gender	Female
Speciality	Nurse Practitioner - Pediatrics
Location	318 Ruhle Rd S, Ballston Lake, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1760697049
Provider Enumeration Date: 05/11/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Christine Lange such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1760697049	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LP0200X	Nurse Practitioner - Pediatrics	F330876-1 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christine Lange is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Christine Lange, 318 Ruhle Rd S, Ballston Lake, NE 12019 Ph: (518) 899-4133	Christine Lange, 318 Ruhle Rd S, Ballston Lake, NE 12019 Ph: (518) 899-4133

News Archive

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Sorrento Therapeutics, Inc. today announced that it has received an Advanced Technology Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus infections, including methicillin-resistant S. aureus, by disrupting quorum sensing, a bacterial communication process essential to virulence.

Osteoarthritis susceptibility: eight potential genes discovered

The largest genome-wide association study (GWAS) of osteoarthritis to date, published Online First in The Lancet, has uncovered eight new genetic variants or loci that appear to increase susceptibility to the most common form of arthritis, which affects about 40% of the world population older than 70 years. These findings bring the total number of osteoarthritis susceptibility genes isolated in European populations to 11.

Mount Sinai researchers win a contract from DARPA to develop technology that measures threat exposures

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a contract from the Defense Advanced Research Projects Agency, a research agency within the U.S. Department of Defense, to find molecular signatures in blood that identify previous exposures and time of exposure to materials that could be associated with weapons of mass destruction (including infectious agents, chemicals, and radiation).

Thyroid surgery can be done safely in an outpatient setting

Thyroid surgery, which has traditionally been an overnight hospital procedure, can be done safely in an outpatient setting, and in fact is preferable because it is less expensive, according to a new study published in the April issue of Otolaryngology-Head and Neck Surgery .

Christine Lange, - Nurse Practitioner in Ballston Lake, NE